The success of clinical trials of selective B-cell depletion in patients with relapsing multiple sclerosis (MS) and primary progressive MS has led to a conceptual shift in the understanding of MS pathogenesis, away from the classical model in which T cells were the sole central actors and toward a m...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!